Alex Zhavoronkov (Insilico)

Weeks af­ter launch, Alex Zha­voronkov's AI-in­spired longevi­ty spin­out sells to Hong Kong-list­ed group

When Alex Zha­voronkov un­veiled In­sil­i­co’s longevi­ty-fo­cused spin­out, he kept the pre­cise amount of Se­ries A fund­ing un­der wraps — dis­clos­ing on­ly that it’s in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA